Early events in angiogenesis: Cloning an a-prolyl 4-hydroxylase-like gene

International Journal of Oncology

Volumn 13, Issue 3, 1998, Pages 595-600

  Cockerill, Gillian W ^a,c   Varcoe, Lorena ^a   Meyer, Geoffrey T ^b   Vadas, Mathew A ^a   Gamble, Jennifer R ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Collagen; Endothelial; Extracellular matrix; Hydroxylation; Subtractive hybridization

Indexed keywords

ALPHA PROLYL 4 HYDROXYLASE; COLLAGEN; COMPLEMENTARY DNA; HISTIDINE; MATRIGEL; OXYGENASE; RIBONUCLEASE; UNCLASSIFIED DRUG;

ANGIOGENESIS; ARTICLE; CAPILLARY; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; PRIORITY JOURNAL; UMBILICAL VEIN;

AMINO ACID SEQUENCE; CLONING, MOLECULAR; COLLAGEN; DNA, COMPLEMENTARY; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; HUMANS; LAMININ; MOLECULAR SEQUENCE DATA; NEOVASCULARIZATION, PHYSIOLOGIC; PROCOLLAGEN-PROLINE DIOXYGENASE; PROTEOGLYCANS; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; SEQUENCE HOMOLOGY, AMINO ACID; TRANS-ACTIVATION (GENETICS); UMBILICAL VEINS; UP-REGULATION;

EID: 0031876638     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Folkman J: Tumor angiogenesis. Adv Cancer Res 43: 374-203, 1975.
2. Folkman J: Angiogenesis and its inhibitors. In: Important Advances in Oncology. DeVita VT Jr, Hellman S and Roseberg SA (eds). Lippincott, Philadelphia, pp42-62, 1985.
3. D'Amore PA and Thompson RW: Mechanisms of angiogenesis. Annu Rev Physiol 49: 453-464, 1987.
4. Zetter BR: Angiogenesis. State of the art. Chest 93: 159S-166S, 1988.
5. Blood CH and Zetter BR: Tumor interaction with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032: 89-118, 1990.
6. Moscatelli D and Rifkin DB: Membrane and matrix localisation of proteinase: a common theme in tumour cell invasion and angiogenesis. Biochim Biophys Acta 948: 67-85, 1988.
7. Folkman J and Klagsbun M: Angiogenic Factors. Science 253: 442-447, 1987.
8. Folkman J and Haudenschild BC: Angiogenesis in vitro. Nature 288: 551-556, 1980.
9. Maciag T, Kadish J, Wilkins L, Stemerman MB and Weinstein R: Organizational behaviour of human vein endothelial cells. J Cell Biol 97: 153-166, 1982.
10. Madri JA and Pratt BM: Endothelial cell - matrix interactions in vitro models of angiogenesis. J Histochem Cytochem 34: 85-91, 1986.
11. Montesano R and Orci L: Tumor-promoting phorbol ester induce angiogenesis in vitro. Cell 42: 469-477, 1987.
12. Kleinman HK, McGarvey ML, Liotta LA, Robey PG, Tryggvason K and Martin GR: Isolation and characterisation of type IV procollagen, laminin, and heparin sulfate proteoglycan from the EHS sarcoma. Biochemistry 21: 6188-6193, 1982.
13. Grant DS, Tashiro KI, Segui-Real B, Yamada Y, Martin GR and Kleinman HK: Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 58: 933-943, 1989.
14. Risau W and Lemmon V: Changes in the vascular extracellular matrix during embryonic vasculogenesis and angiogenesis. Dev Biol 125: 441-450, 1988.
15. Rooney P, Kumar P, Ponting JM and Kumar S: The role of glycosaminoglycans and type VIII collagen in tumour angiogenesis. In: Tumour Angiogenesis. Biknell R, Lewis CE and Ferrara N (eds). Oxford University, pp141-161, 1997.
16. Wall RT, Harker LA, Quadracci LJ and Striker GE: Factors influencing endothelial cell proliferation in vitro. J Cell Physiol 96: 203-213, 1978.
17. Belyavsky A, Vinogradova T and Rajewsky K: PCR-based cDNA library construction: general cDNA libraries at the level of a few cells. Nucleic Acids Res 17: 2919-2932, 1989.
18. Cockerill PN, Shannon MF, Bert AG, Ryan GR and Vadas MA: The granulocyte-macrophage colony-stimulating factor/ interleukin 3 locus is regulated by an inducible cyclosporin A-sensitive enhancer. Proc Natl Acad Sci USA 90: 2466-2470, 1993.
19. Kleinman HK, McGarvey ML and Hassel JR: Basement membrane complexes with biological activity. Biochemistry 25: 312-318, 1986.
20. Li ML, Aggeler J, Forson DA, Hatier C, Hassel J and Bissel MJ: Influence of a reconstitute basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc Natl Acad Sci USA 84: 136-140, 1987.
21. Bendayan M, Duhir MA and Gungros D: Studies on pancreatic acinar cells in tissue culture. Basement membrane matrix promotes 3D reorganisation. Eur J Cell Biol 42: 60-67, 1986.
22. Kubota Y, Kleinman HK, Martin GR and Lawley TJ: Role of laminin and basement membrane in the morphological differentiation of human endothelial cells in capillary-like structures. J Cell Biol 107: 1589-1598, 1988.
23. Grant DS, Lelkes PI, Fukuda K and Kleinman HK: Intracellular mechanism involved in basement membrane induced blood vessel differentiation. In Vitro Cell Dev Biol 27A: 327-336, 1991.
24. Kato M, Koike Y, Suzuki S and Kimata K: Characterisation using monoclonal antibodies to Engelbreth-Holm-Swarm tumor low density heparan sulfate proteoglycan. J Cell Biol 106: 2203-2210, 1988.
25. Ingber DE and Folkman J: How does the extracellular matrix control capillary morphogenesis? Cell 58: 803-805, 1989.
26. Madri JA, Williams SK, Wyatt T and Mezzio C: Capillary endothelial cell cultures: phenotype modulation by matrix components. J Cell Biol 97: 153-166, 1983.
27. Maragondakis ME, Sarmonica M and Panoutsacopoulos M: Inhibition of basement membrane synthesis as an index of angiogenesis. J Pharm Exp Ther 244: 729-733, 1988.
28. McAuslen BR, Reilly W, Hannan GN, Schindhelm K, Millharpe B and Saur BA: Induction of endothelial cell migration by proline analogs and its relevance to angiogenesis. Exp Cell Res 176: 248-257, 1988.
29. Grant DS, Kleinman HK and Martin GR: The role of basement membrane in vascular development. Ann NY Acad Sci 588: 61-72, 1989.
30. Dziadek M, Paulsson M, Aumalley M and Timpl R: Purification and tissue distribution of a small protein (BM-40) extracted from a basement membrane tumor. Eur J Biochem 161: 455-464, 1986.
31. Iruela-Arispe ML, Borstein P and Sage H: Thrombospondin exerts an anti-angiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci USA 88: 5026-5030, 1991.
32. 2+-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells. Proc Natl Acad Sci USA 88: 2648-2652, 1991.
33. Mignatti P, Tsuboi R, Robbins E and Rifkin DB: In vitro angiogenesis on the human amniotic membrane; requirement for basic fibroblast growth factor-induced proteinases. J Cell Biol 108: 671-682, 1989.
34. Folkman J and Klagsbrun M: Angiogenic factors. Science 235: 442-447, 1986.
35. Gospodarowicz D and Cheng J: Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 128: 475-484, 1986.
36. Taub M, Wang Y, Szensny MT and Kleinman HK: Epidermal growth factor or transforming growth factor alpha is required for kidney tubulogenesis in matrigel cultured in serum free medium. Proc Natl Acad Sci USA 87: 4002-4006, 1990.
37. Wolf FW, Marks RM, Sarma V, Byers MG, Katz RW, Show TB and Dixit VM: Characterisation of a novel TNFα-induced endothelial primary response gene. J Biol Chem 34: 85-91, 1991.
38. Bauer J, Margolis M, Schreiner C, Edgell C-J, Azizkhen J, Lazarowski E and Juliano RL: In vitro model of angiogenesis using a human endothelial derived permanent cell line: Contribution of induced gene expression, G proteins and integrins. J Cell Physiol 153: 437-449, 1992.
39. Laterra J and Goldstein GW: Astroglial-induced in vitro angiogenesis: requirement for RNA and protein synthesis. J Neurochem 57: 1231-1239, 1990.
40. Kivirikko KI, Helaakoski T, Tasanen K, Vuori K, Myllyla R, Parkkonen T and Pihlajaniemi T: Molecular biology of prolyl 4-hydroxylase. Collagen Biosynthesis and Supramolecular Assembly. Ann NY Acad Sci 580: 132-142, 1980.
41. Kivirikko KI and Myllyla R: Hydoxylation of prolyl and lysyl residues. In: The Enzymology of Post-translational Modification of Proteins. Freedman RB and Hawkins CH (eds). Academic Press, London, pp53-104, 1980.
42. Kivirikko KI and Myllyla R: Post-translational processing of procollagens. Ann NY Acad Sci 460: 187-201, 1985.
43. Kivirikko KI, Myllyla R and Pihlajaniemi T: Protein hydroxylation: prolyl 4-hydroxylase, an enzyme with four co-substrates and a multifunctional subunit. FASEB J 3: 1609-1617, 1989.
44. Kawaguchi Y, Kitani A, Hara M, Harigai M, Hirose T, Suzuki K, Kawakami M, Hikada T, Ishizuka T, Kawagoe M and Nakamura H: Cytokine regulation of prolyl 4-hydroxylase in skin fibroblast cultures from patients with systemic sclerosis: contribution to collagen synthesis and fibrosis. J Rheumatol 19: 1195-1201, 1992.
45. LeRoy EC: Increased collagen synthesis by scleroderma skin fibroblasts in vitro. A possible defect in the regulation or activation of the scleroderma fibroblasts. J Clin Invest 54: 880-889, 1974.
46. Medsger TA Jr: Systemic sclerosis (scleroderma), localised scleroderma, eosinophilic fascitis, and calcinosis. In: Arthritis and Allied Conditions. McCarthy DJ (ed). 11th edition, Lea and Febiger, Philadelphia, pp1118-1165, 1989.
47. Helaakoski T, Pajunen L, Kivirikko KI and Pihlajaniemi T: Increases in mRNA concentrations of the α and β subunits of proly 4-hydroxylase accompany increased gene expression of type IV collagen during differentiation of mouse F9 cells. J Biol Chem 265: 11413-11416, 1990.
48. Helaakoski T, Veijola J, Vuori K, Rehn M, Chow LT, Taillon-Miller P, Kivirikko KI and Pihlajaniemi T: Structure and expression of the human gene for the a subunit of proly 4-hydroxylase. J Biol Chem 269: 27847-27854, 1994.
49. Haralabopoulos GC, Grant DS, Kleinman HK, Lelkes PI, Papaioannou SP and Maragoudakis ME: Inhibitors of basement membrane collagen synthesis prevent endothelial cell alignment on matrigel in vitro and angiogenesis in vivo. Lab Invest 71: 575-582, 1994.